Enhanced Oral Bioavailability Using Spray-Dried Dispersions

An estimated 25-30% of compounds in early development have poor bioavailability due to low solubility, representing a significant loss in economic and therapeutic opportunity. Because many of these low-solubility compounds have the potential to be safe and effective, it is critical they advance. To address this growing need, Bend Research has developed a patented delivery platform based on spray-dried dispersions.

Topics: 
Bioavailability Enhancement